Trefoil Therapeutics
Trefoil was founded to bring forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD153—229m (Dealroom.co estimates Dec 2021.)
San Diego California (HQ)
Authorizing premium user...